©ufs understanding complete blood counts the abcs of cbcs robert miceli, md metlife
TRANSCRIPT
2 For Financial Professional Use Only
The Good, The Bad, and The Ugly
Common Abnormal but Benign CBCs
(CBC may be accepted without repeat CBC or clinical evaluation)
• Mild iron deficiency anemia in pre-menopausal women
• Beta thalassemia minor
• Chronic benign neutropenia
• Reactive thrombocytosis
Abnormal / Worrisome CBCs
(may require additional follow-up or clinical evaluation)
• Iron deficiency anemia in men or post-menopausal women
• Mild or moderate anemia, not fully evaluated
• Unexplained thrombocytopenia or thrombocytosis
• Mild abnormalities involving all 3 cell lines (red cells, white cells, and platelets), mild pancytopenia
Markedly Abnormal CBCs
• Leukemia
• Severe anemia
• Severe leukopenia or severe pancytopenia
3 For Financial Professional Use Only
What Are the Major Components of Blood?
• Red Blood Cells (also called erythrocytes)
• White Blood Cells (also called leukocytes)
• Platelets (also called thrombocytes)
• Plasma
4 For Financial Professional Use Only
Fancy Words for High and Low
Cell Type Too High Too Low
Red Blood Cells (Erythrocytes)Erythrocytosis or
PolycythemiaAnemia
Platelets (Thrombocytes)Thrombocytosis or Thrombocythemia
Thrombocytopenia
White Blood Cells (Leukocytes) Leukocytosis Leukopenia
Neutrophils Neutrophilia Neutropenia
Lymphocytes Lymphocytosis Lymphopenia
Eosinophils Eosinophilia ---
Monocytes Monocytosis ---
Basophils Basophilia ---
5 For Financial Professional Use Only
Symptoms
Factor Too Much Too Little
RBCs Clots, strokesShortness of breath
(dyspnea), hypoxia, fatigue, pallor
WBCs Clots, strokes Infections
Platelets Clots, strokes Bleeding
6 For Financial Professional Use Only
Hematology Tests
• Specialized tests– Bone Marrow aspiration and biopsy
• All of the formed elements of the blood are produced primarily in the bone marrow
• They are produced by progenitor cells – cells which grow and differentiate into mature formed elements
• This test can detect the lack or overabundance of these progenitor cells, and can find other problems such as cancer
8 For Financial Professional Use Only
Red Blood Cells (RBCs)
• Largest cellular component of blood, about 40-45% of blood volume
• Comprised mostly of hemoglobin
• Transport oxygen
• Red blood cells normally last about 120 days before they are removed by the spleen
9 For Financial Professional Use Only
Hemoglobin
• Red pigment molecule which gives RBCs (and blood) its color
• Contains 4 molecules of heme and 4 of globin (2 alpha chains and 2 beta chains)
• Each molecule of heme contains one iron ion
10 For Financial Professional Use Only
White Blood Cells
• There are several types of White Blood Cells
• They are all involved in immunity but in somewhat different ways
– Granulocytes (neutrophils, PMNs, polymorphonuclear leukocytes, or “polys”) – involved in acute infections with bacteria. Immature form is called a “band”
– Lymphocytes – involved in many types of infection, especially viruses -Produce antibodies and “memory cells” - Are further divided into T-cells and B-cells
– Eosinophils – involved in parasitic infections and allergies
– Basophils – involved in parasitic infections and allergies
– Monocytes – involved in bacterial and parasitic infections
11 For Financial Professional Use Only
White Blood Cells (WBCs)
• Neutrophils – also called a variety of other names on CBC reports, including:– polys
– PMNs
– segs
– grans
• Lymphocytes
• Monocytes
• Eosinophils
• Basophils
12 For Financial Professional Use Only
Platelets
• Really more of a fragment of a cell– They are broken off from a
very large cell in the bone marrow called a megakaryocyte
– Primary function is to aid in blood clotting
– Lifetime in the blood is 7-10 days after which they are destroyed in the spleen
– Their clotting function is permanently inhibited by aspirin
13 For Financial Professional Use Only
Plasma
• Plasma is the liquid component of blood
• Comprised mostly of water, but also includes:
– Protein (albumin, globulin, fibrinogen)
– Lipids (cholesterol, triglycerides)
– Dissolved salts and minerals (sodium, calcium, potassium)
– Glucose
14 For Financial Professional Use Only
Case # 1
• 32 yo female applying for $1 million whole life
• Insurance labs show elevations of total cholesterol at 240 and alkaline phosphatase at 170, other labs are normal
• Medical records include CBC from 1 month prior to application, done during routine office visit.
TEST RESULT UNITS REF RANGE WBC 10.8 x 1000/mm3 3.9 - 11.1 RBC 3.73 L x 106/mm3 4.00 - 5.20 HGB 10.8 L g/dL 12.0 - 16.0 HCT 32.4 L % 38.5 - 49.0 MCV 84 fl 80 - 97 MCH 31.0 pg 27.5 - 33.5 MCHC 33.3 % 32.0 - 36.0 PLT 310 x 1000/mm3 150 - 350
• Paramedical exam: currently pregnant
15 For Financial Professional Use Only
“Anemia” of Pregnancy
• During pregnancy, the volume of red blood cells increases by about 20%, but the plasma volume increases by 45%.
• Net result is ≈ 15% decrease in hemoglobin and hematocrit.
16 For Financial Professional Use Only
Complete Blood Count (CBC)
TEST RESULT UNITS REF RANGE WBC 5.2 x 1000/mm3 3.9 - 11.1 RBC 3.81 L x 106/mm3 4.20 - 5.70 HGB 14.5 g/dL 13.2 - 16.9 HCT 41.2 % 38.5 - 49.0 MCV 98 H fl 80 - 97 MCH 33.7 H pg 27.5 - 33.5 MCHC 35.3 % 32.0 - 36.0 RDW 11.8 % 11.0 - 15.0 PLT 172 x 1000/mm3 140 - 390 MPV 7.6 fl 7.5 - 11.5 NEUT % 40.1 % 38.0 - 80.0 LYMPH % 46.1 % 15.0 - 49.0 MONO % 12.9 % 0.0 - 13.0 EOS % 0.6 % 0.0 - 8.0 BASO % 0.3 % 0.0 - 2.0 NEUT, ABS 2085 cells/mm3 1650 - 8000 LYMPH, ABS 2397 cells/mm3 1000 - 3500 MONO, ABS 671 cells/mm3 40 - 900 EOS, ABS 31 cells/mm3 30 - 600 BASO, ABS 16 cells/mm3 0 - 125
17 For Financial Professional Use Only
Red Blood Count and RBC Indices
TEST RESULT UNITS REF RANGE WBC 5.2 x 1000/mm3 3.9 - 11.1 RBC 3.81 L x 106/mm3 4.20 - 5.70 HGB 14.5 g/dL 13.2 - 16.9 HCT 41.2 % 38.5 - 49.0 MCV 98 H fl 80 - 97 MCH 33.7 H pg 27.5 - 33.5 MCHC 35.3 % 32.0 - 36.0 RDW 11.8 % 11.0 - 15.0 PLT 172 x 1000/mm3 140 - 390 MPV 7.6 fl 7.5 - 11.5 NEUT % 40.1 % 38.0 - 80.0 LYMPH % 46.1 % 15.0 - 49.0 MONO % 12.9 % 0.0 - 13.0 EOS % 0.6 % 0.0 - 8.0 BASO % 0.3 % 0.0 - 2.0 NEUT, ABS 2085 cells/mm3 1650 - 8000 LYMPH, ABS 2397 cells/mm3 1000 - 3500 MONO, ABS 671 cells/mm3 40 - 900 EOS, ABS 31 cells/mm3 30 - 600 BASO, ABS 16 cells/mm3 0 - 125
18 For Financial Professional Use Only
Measuring RBCs (and the “Rule of Threes”)
• Hematocrit (HCT) is the percent of a volume of whole blood occupied by intact red blood cells. Measured in percent.– Normal range for women: 36 - 46%
– Normal range for men: 41 - 53%
• Hemoglobin (HGB) measures the concentration of hemoglobin expressed as grams of hemoglobin per deciliter (100 ml) of whole blood.– Normal range for women: 12 - 16 g/dL
– Normal range for men: 13.5 - 17.5 g/dL
• RBC count is the number of red blood cells per microliter of whole blood. Measured in millions of RBCs per microliter of whole blood.– Normal range for women: 4.0 - 5.2 x106/mm3
– Normal range for men: 4.5 - 5.9 x106/mm3
19 For Financial Professional Use Only
Red Blood Cell Indices
• Mean Corpuscular Volume (MCV) is the average size of red blood cells.– Normal range: 80-100 fL– Low = “microcytic” (“too small”) High = “macrocytic” (“too big”)
Normal = “normocytic” (“just right”)
• Red Cell Distribution Width (RDW) measures the variability in the size of red blood cells. – Normal range: 11.5-14.5%– On a peripheral blood smear, high RDW is described as “anisocytosis”
• Mean Corpuscular Hemoglobin (MCH) is the amount of hemoglobin in an average red blood cell.– Normal range: 26-34 pg/cell
• Mean Corpuscular Hemoglobin Concentration (MCHC) is the average concentration of hemoglobin in an average RBC.– Normal range: 31-37 g/dL– “Hypochromic” = “too pale” “Normochromic” = “just right”
20 For Financial Professional Use Only
Red Blood Cell Indices
• Mean Corpuscular Volume (MCV) is the average size of red blood cells.– Normal range: 80-100 fL– Low = “microcytic” (“too small”) High = “macrocytic” (“too big”)
Normal = “normocytic” (“just right”)
• Red Cell Distribution Width (RDW) measures the variability in the size of red blood cells. – Normal range: 11.5-14.5%– On a peripheral blood smear, high RDW is described as “anisocytosis”
• Mean Corpuscular Hemoglobin (MCH) is the amount of hemoglobin in an average red blood cell.– Normal range: 26-34 pg/cell
• Mean Corpuscular Hemoglobin Concentration (MCHC) is the average concentration of hemoglobin in an average RBC.– Normal range: 31-37 g/dL– “Hypochromic” = “too pale” “Normochromic” = “just right”
21 For Financial Professional Use Only
Red Blood Cell Indices
• Mean Corpuscular Volume (MCV) is the average size of red blood cells.– If anemia is present, MCV is a useful tool to guide further testing
– If anemia is not present, MCV is of little value:
• Low MCV without anemia suggests thalassemia minor (trait)
• High MCV without anemia can be caused by certain medications (Dilantin, oral contraceptives, methotrexate) and is a “soft” marker of possible alcohol overuse
• Red Cell Distribution Width (RDW) measures the variability in the size of red blood cells. – Not useful in the absence of anemia
22 For Financial Professional Use Only
Classification of Anemias Using MCV and RDW
Low MCV (Microcytic)
Normal MCV (Normocytic)
High MCV (Macrocytic)
Low RDW (low variability)
Thalassemia minor
Normal RDW
Thalassemia minor
Anemia of chronic disease
Anemia of chronic disease
Hereditary spherocytosis
Aplastic anemia
Myelodysplastic syndrome
High RDW (high variability)
Iron deficiency
Early deficiency of iron, B12, or folate
Sickle cell anemia
B12 or folate deficiency
Hemolytic anemia
23 For Financial Professional Use Only
Descriptive Terms Used on Peripheral Smears
• Anisocytosis: marked variation in RBC sizes (visual counterpart of increased RDW)
• Hypochromia or hypochromasia: RBCs are paler than normal because they contain less hemoglobin (visual counterpart of decreased MCH)
• Macrocytosis: increased number of large RBCs (visual counterpart of increased MCV)
• Microcytosis: increased number of small RBCs (visual counterpart of decreased MCV)
• Poikilocytosis: marked variation in the shape of RBCs
24 For Financial Professional Use Only
Reticulocyte Count
• Reticulocytes are “young” red blood cells that were recently released from the bone marrow.
• Normally, reticulocytes comprise 0.5 - 2.5% of all red blood cells.
• Increased reticulocytes (reticulocytosis) is a normal response to blood loss or anemia. Since reticulocytes are larger, the MCV (and RDW) may be elevated.
• The combination of anemia with a low or normal reticulocyte count indicates that the bone marrow is unable to respond normally, either due to lack of essential ingredients (iron deficiency, vitamin B12 or folate deficiency), bone marrow disease, or chronic disease.
25 For Financial Professional Use Only
Anemia
• Low RBCs – two ways to get there: Too little production, or increased destruction
• Low production– Aplastic anemia (no production)– Iron Deficiency Anemia
• Increased Destruction– Hemolytic anemia– Spherocytosis– Hemoglobin disorders (thalassemia, sickle cell, others)– Hemorrhage (blood loss)– Hypersplenism (an overactive spleen which destroys formed elements
prematurely)
• Regardless of the type of anemia, once the level of hemoglobin/hematocrit gets sufficiently low, mortality may result
• Mortality Concerns– Severe anemia may cause a critical lack of oxygen to the brain or heart– Less severe anemia may still worsen chronic heart or lung conditions
26 For Financial Professional Use Only
Iron deficiency/hemorrhagic anemia
• The oxygen-carrying protein heme contains iron, and gives blood its red color
• If iron levels are low, RBCs cannot be produced fast enough to match losses
• Iron-deficiency anemia is the most common form of anemia world-wide– May be due to poor intake of iron or chronic loss of blood– Blood is lost most commonly from the GI tract
• The most important factor to consider when underwriting this condition is – What is the cause?– Possibilities include
• Stomach ulcers• Colon cancer• Vascular malformations in the GI tract• Endometrial cancer• Recent surgery or trauma• Multiple blood donations
• Can be treated with iron supplements, blood transfusion and/or eradication of the cause
27 For Financial Professional Use Only
Case # 2
• 57 yo male applying for $250,000 whole life
• Paramedical exam: mild type 2 diabetes, controlled on oral medications, HbA1c 6.1%
• APS: routine follow-up for diabetes, no complications, CBC done as routine test
TEST RESULT UNITS REF RANGE
WBC 7.5 x 1000/mm3 3.9 - 11.1
RBC 3.46 L x 106/mm3 4.60 - 6.20
HGB 10.1 L g/dL 14.0 - 18.0
HCT 29.6 L % 40.0 - 54.0
MCV 85.6 fl 80 – 94
MCH 29.3 pg 27 - 33
MCHC 34.2 % 32.0 - 36.0
RDW 13.9 % 11.0 - 15.0
PLT 222 x 1000/mm3 140 - 390
NEUT % 58.0 % 40 - 79
LYMPH % 29.5 % 15 - 45
MONO % 7.0 % 0 - 11
EOS % 5.2 % 0 - 6 BASO % 0.3 % 0 - 3
NEUT, # 4.4 x103 uL 1.8 - 8.7
LYMPH, # 2.2 x103 uL 0.7 - 5.0
MONO, # 0.5 x103 uL 0.0 - 1.2
EOS, # 0.4 x103 uL 0.0 - 0.7
BASO, # 0 x103 uL 0.0 - 0.3
28 For Financial Professional Use Only
Case # 2 (continued)
• Serum vitamin B12 and folate levels were normal
• Iron studies showed low serum ferritin and a low transferrin saturation, consistent with iron deficiency
• Colonoscopy was normal
• Upper endoscopy showed moderate gastritis and esophagitis with no evidence of active bleeding
• Hemoglobin improved with administration of iron
Iron-poor RBCs are pale and small (low MCV and MCH)
29 For Financial Professional Use Only
Megaloblastic Anemia
• A diverse group of anemias, all of which show elevated MCV on the blood count
• May be caused by:– Vitamin deficiency (usually B12 or folic acid)– Alcohol intake (moderately high levels)– Leukemia (WBCs would be abnormal, too)– Certain medications
• Pernicious anemia – vitamin B12 deficiency caused by an inability to absorb the vitamin from the GI tract. May cause neuropathy, weakness, or even psychiatric problems
• Usually treated by– Determining and eliminating the cause– Correcting the vitamin deficiency (if any)
• May require injections of vitamin B12 if the cause is pernicious anemia
• Mortality concerns – determined by the underlying cause and severity of anemia
30 For Financial Professional Use Only
Autoimmune Hemolytic Anemia
• A condition where the immune system attacks and destroys red blood cells
• Two forms:
– Warm antibody
– Cold Agglutinin disease
• Both cause:
– Normocytic anemia with antibodies against red blood cells (positive Coomb’s test)
• Mortality concerns
– Severity of anemia (hemolytic crises may be fatal)
– Presence of an underlying cause (such as infection or rheumatologic disease – like rheumatoid arthritis)
– Need for side-effect prone treatments such as steroids, immunosuppressants, or frequent blood transfusions
31 For Financial Professional Use Only
Hereditary Spherocytosis/Elliptocytosis
• A disorder of red cell shape where the misshapen cells are taken up by the spleen and destroyed prematurely
• Leads to anemia and splenomegaly
• Splenectomy will normalize the blood count and resolve the anemia, but the cells will still be misshapen
• Mortality Concerns:
– Severity of hemolysis or anemia
– Overwhelming infection after splenectomy
32 For Financial Professional Use Only
Anemia of Chronic Disease
• Also known as anemia of chronic inflammation
• May occur in association with a wide variety of chronic diseases, especially inflammatory conditions, chronic infection, liver disease, congestive heart failure, diabetes, and cancer.
• Anemia is usually mild (Hgb 9-12, Hct 27-35), but can be lower in about 20% of cases.
• MCV is usually normal or low normal
• Platelets may be elevated, especially if inflammation is prominent
33 For Financial Professional Use Only
Hemoglobin Disorders
• These are various, largely genetic, disorders which affect hemoglobin
• Those which affect globin:
– Thalassemias
– Sickle cell and related disorders
• Those which affect heme:
– Porphyrias
34 For Financial Professional Use Only
Thalassemias
• Inherited disorders of the globin gene leading to low levels of alpha or beta globin chains
• Fatalities are unusual in all but the most severe forms
• Alpha Thalassemia: Beta Thalassemia major
– Hemoglobin H disease
– Alpha Thalassemia Trait
• Beta Thalassemia:
– Beta Thalassemia major
– Beta Thalassemia intermedia
– Beta Thalassemia minor (trait)
• Prevalence as high as 10% in Mediterranean, African, and Southeast Asian populations
• Typically mild anemia with marked microcytosis
• Can coexist with other hemoglobin abnormalities, with increased severity of the anemia and increased mortality concern, but true beta-thalassemia minor (trait) has no excess mortality concerns
35 For Financial Professional Use Only
Case # 3
• 47 yo female applying for $1.5 million term
• Paramedical exam: all questions answered “no”
• Insurance labs normal
• Medical records: routine gynecologic visits, CBC done as part of routine exam last year
TEST RESULT UNITS REF RANGE
WBC 4.7 x 109/L 4.4 - 11.3
RBC 5.6 x 1012/L 4.7 - 6.1
HGB 10.5 L g/dL 12.3 - 15.3
HCT 31.6 L
% 35.9 - 44.6
MCV 65.8 L fL 80 - 96
MCH 19.9 L pg 27.5 - 33.2
MCHC 26.7 L % 33.4 - 35.5
RDW 13.0 % 11.5 - 14.5
PLT 249 x 109/L 100 - 450
36 For Financial Professional Use Only
Underwriting Tip: Identifying β-thalassemia minor
Beta-Thalassemia Minor Iron Deficiency Anemia
• RBC count normal or high-normal, usually over 5
• RBC count low-normal or low, almost always less than 5
• Violates “Rule of 3s” (hemoglobin is less than 3 times the RBC count)
• Usually follows “Rule of 3s” (hemoglobin is roughly 3 times the RBC count)
• MCV usually quite low (60-70) even when anemia is mild
• MCV doesn’t become that low unless anemia is quite severe
• RDW is usually normal or low • RDW is often high
37 For Financial Professional Use Only
Sickle Cell Disease
• Forms of hemoglobin:– “A” – adult normal hemoglobin– “S” – sickle cell hemoglobin– “C” – mutant hemoglobin, but with a different result
• Since each person has 2 genes, several combinations are possible– “SA” – Sickle trait, may have minimal sickle cell formation, but
otherwise is basically a carrier– “SS” – affected with sickle cell disease can be mild to severe– “SC” – similar to SS but milder– “CC”- similar to SS but quite a bit milder
Sickle Cell Disease:
• When oxygen level is low, RBCs assume a sickle shape, and block capillaries, leading to severe bone pain, and infarctions in various organs
• Death can occur from infection, severe anemia, stroke or heart attack
38 For Financial Professional Use Only
Porphyria
• A large variety of genetic disorders which affect the biosynthesis of heme
• All are rare
• May cause episodes of severe abdominal pain, sensitivity to sunlight, even psychiatric problems or paralysis
• Mortality Concerns
– Fatalities are quite rare, may occur in the most severe case
39 For Financial Professional Use Only
White Blood Count with Differential
TEST RESULT UNITS REF RANGE WBC 5.2 x 1000/mm3 3.9 - 11.1 RBC 3.81 L x 106/mm3 4.20 - 5.70 HGB 14.5 g/dL 13.2 - 16.9 HCT 41.2 % 38.5 - 49.0 MCV 98 H fl 80 - 97 MCH 33.7 H pg 27.5 - 33.5 MCHC 35.3 % 32.0 - 36.0 RDW 11.8 % 11.0 - 15.0 PLT 172 x 1000/mm3 140 - 390 MPV 7.6 fl 7.5 - 11.5 NEUT % 40.1 % 38.0 - 80.0 LYMPH % 46.1 % 15.0 - 49.0 MONO % 12.9 % 0.0 - 13.0 EOS % 0.6 % 0.0 - 8.0 BASO % 0.3 % 0.0 - 2.0 NEUT, ABS 2085 cells/mm3 1650 - 8000 LYMPH, ABS 2397 cells/mm3 1000 - 3500 MONO, ABS 671 cells/mm3 40 - 900 EOS, ABS 31 cells/mm3 30 - 600 BASO, ABS 16 cells/mm3 0 - 125
40 For Financial Professional Use Only
Absolute Neutrophil Count
TEST RESULT UNITS REF RANGE WBC 5.2 x 1000/mm3 3.9 - 11.1 RBC 3.81 L x 106/mm3 4.20 - 5.70 HGB 14.5 g/dL 13.2 - 16.9 HCT 41.2 % 38.5 - 49.0 MCV 98 H fl 80 - 97 MCH 33.7 H pg 27.5 - 33.5 MCHC 35.3 % 32.0 - 36.0 RDW 11.8 % 11.0 - 15.0 PLT 172 x 1000/mm3 140 - 390 MPV 7.6 fl 7.5 - 11.5 NEUT % 40.1 % 38.0 - 80.0 LYMPH % 46.1 % 15.0 - 49.0 MONO % 12.9 % 0.0 - 13.0 EOS % 0.6 % 0.0 - 8.0 BASO % 0.3 % 0.0 - 2.0 NEUT, ABS 2085 cells/mm3 1650 - 8000 LYMPH, ABS 2397 cells/mm3 1000 - 3500 MONO, ABS 671 cells/mm3 40 - 900 EOS, ABS 31 cells/mm3 30 - 600 BASO, ABS 16 cells/mm3 0 - 125
5.2 x 1000 = 5200
5200 x .401 = 2085
41 For Financial Professional Use Only
Underwriting Tip
• If the total white blood count (WBC) is normal, the red cells and platelets are normal, and your applicant is otherwise healthy, don’t worry about the differential white blood count, especially if the absolute counts are normal.
• The percentage of neutrophils, lymphocytes, etc. often fluctuate in response to an infection; this is not a big underwriting concern.
42 For Financial Professional Use Only
• Neutrophils – also called a variety of other names on CBC reports, including:– polys
– PMNs
– segs
– bands or stabs (immature neutrophils indicate acute infection)
• Lymphocytes
• Monocytes
• Eosinophils
• Basophils
Types of White Blood Cells - What’s the Diff?
43 For Financial Professional Use Only
WBC Differential: Neutrophils
Possible Causes of Neutrophilia:
Possible Causes of Neutropenia:
Common: bacterial infections, inflammatory disorders, stress, certain drugs (especially prednisone), pregnancy
Rare: leukemias
Common: chronic benign neutropenia (some forms are familial), chemotherapy
Uncommon: systemic lupus erythematosus, immunodeficiency states
44 For Financial Professional Use Only
Leukocytosis
• An elevated WBC count is termed “leukocytosis”
• Normal level is 4,400 to 10,000 WBC per mm3
• This can result from many causes, principally infections, inflammatory disorders, and medications
• Cancer and myeloproliferative disorders can also cause high, sometimes extremely high, WBC counts
• Treatment is aimed at the underlying cause
• Death may result from the underlying cause such as severe infection or cancer (leukemia)
45 For Financial Professional Use Only
Neutropenia
• The relative lack of neutrophils (the most common type of WBC, also called granulocytes)
• Normally humans have at least 1500 neutrophils/mm3
• Severe neutropenia (almost no neutrophils) is “agranulocytosis”
• May be cause by gene defects, various drugs, or medical conditions
• Treatment is usually aimed at the underlying cause
• Some may require antibiotics to prevent infection or medications to stimulate production of neutrophils
• Death may occur due to overwhelming infection
Chronic Benign Neutropenia:
• Overall risk of infection is low, usually asymptomatic
• Two forms – familial and non-familial
• Key features from underwriting perspective are the absence of significant infections and stability over time
46 For Financial Professional Use Only
Case # 4
• 44 yo male applying for $2,000,000 whole life
• Paramedical exam: rotator cuff injury to right shoulder, getting physical therapy, elevated cholesterol on Lipitor
• Insurance labs are normal
• Medical records only included labs, no office notes.
TEST RESULT UNITS REF RANGE
WBC 2.8 L x 1000/mm3 3.9 - 11.1
RBC 5.02 x 106/mm3 4.20 - 5.70
HGB 14.9 g/dL 13.2 - 16.9
HCT 45.2 % 38.5 - 49.0
MCV 95 fl 80 - 97
MCH 34.0 H pg 27.5 - 33.5
MCHC 35.1 % 32.0 - 36.0
RDW 13.8 % 11.0 - 15.0
PLT 212 x 1000/mm3 140 - 390
NEUT % 50.2 % 38.0 - 80.0
LYMPH % 36.0 % 15.0 - 49.0
MONO % 13.3 % 0.0 - 13.0
EOS % 0.3 % 0.0 - 8.0
BASO % 0.2 % 0.0 - 2.0
Total WBC x % Neutrophils = ANC
2800 x 50.2% = 1406
47 For Financial Professional Use Only
Case # 4: Additional Information
• Office notes arrive for review with no history of recurrent or serious infections, and WBC has been stable in 2.5 - 4.0 range for the past 5 years. Absolute neutrophil counts are always greater than 1000.
48 For Financial Professional Use Only
WBC Differential: Lymphocytes
Possible Causes of Lymphocytosis:
Possible Causes of Lymphopenia:
Common: viral infections
Uncommon: inflammatory bowel disease
Rare: chronic lymphocytic leukemia, vasculitis
Uncommon: systemic lupus erythematosus, immunodeficiency states
Rare: aplastic anemia, Hodgkin’s disease
49 For Financial Professional Use Only
WBC Differential: Monocytes
Possible Causes of Monocytosis:
Decreased Levels:
Common: recovery phase after infections
Uncommon: certain infections (TB, malaria), inflammatory bowel disease
Rare: myeloproliferative disorders including myeloid metaplasia, polycythemia vera, certain forms of leukemia and lymphoma
- - -
50 For Financial Professional Use Only
WBC Differential: Eosinophils
Possible Causes of Eosinophilia:
Decreased Levels:
Common: allergic disorders (including drug reactions)
Uncommon: parasite infection, lupus, rheumatoid arthritis
Rare: hypereosinophilic syndrome, diffuse skin diseases, some forms of leukemia and lymphoma, Löffler’s endocarditis
- - -
51 For Financial Professional Use Only
Case # 5
• 45 yo female applying for $1 million term
• Paramedical exam: asthma, usually well-controlled with inhalers
• Insurance labs: normal
• Medical records: records from primary care physician confirm that asthma is generally well-controlled, although she did require short-term prednisone in 2007. Also followed by a dermatologist for atopic dermatitis. Records include CBC from 9/08.
TEST RESULT UNITS REF RANGE
WBC 8.2 x 1000/mm3 3.9 - 11.1
RBC 4.5 x 106/mm3 4.2 - 5.7
HGB 13.0 g/dL 12.0 - 16.0
HCT 40.5 % 36.0 - 46.0
MCV 94 fl 80 - 97
MCH 28.0 pg 27.5 - 33.5
MCHC 34.0 % 32.0 - 36.0
RDW 13.4 % 11.0 - 15.0
PLT 372 x 1000/mm3 140 - 390
NEUT % 45.1 % 38.0 - 80.0
LYMPH % 37.6 % 15.0 - 49.0
MONO % 5.3 % 0.0 - 13.0
EOS % 12.0 H % 0.0 - 8.0
BASO % 0.0 % 0.0 - 2.0
NEUT, ABS 3698 cells/mm3 1650 - 8000
LYMPH, ABS
3083 cells/mm3 1000 - 3500
MONO, ABS 435 cells/mm3 40 - 900
EOS, ABS 984 H cells/mm3 30 - 600
BASO, ABS 0 cells/mm3 0 - 125
52 For Financial Professional Use Only
Case # 6
• 45 yo male applying for $1 million term
• Paramedical exam: has seen personal physician for cold and cough, last visit 1 month ago
• Insurance labs: normal
• Medical records: seen in January, March, and August of this year complaining of non-productive cough since December 2008. Chest x-ray showed questionable vague infiltrates in both lung bases. Did not improve with 2 courses of antibiotics or therapeutic trial of asthma inhalers. Upper GI series and upper endoscopy showed no evidence of GERD. On August visit, also noted fatigue and diarrhea.
TEST RESULT UNITS REF RANGE
WBC 9.2 x 1000/mm3 3.9 - 11.1
RBC 4.2 x 106/mm3 4.20 - 5.70
HGB 13.3 g/dL 13.2 - 16.9
HCT 40.2 % 38.5 - 49.0 MCV 96 fl 80 - 97
MCH 32.0 pg 27.5 - 33.5
MCHC 35.3 % 32.0 - 36.0
RDW 11.8 % 11.0 - 15.0
PLT 390 x 1000/mm3 140 - 390
NEUT % 40.1 % 38.0 - 80.0
LYMPH % 29.5 % 15.0 - 49.0
MONO % 9.5 % 0.0 - 13.0
EOS % 20.1 H % 0.0 - 8.0
BASO % 0.9 % 0.0 - 2.0
NEUT, ABS 3689 cells/mm3 1650 - 8000
LYMPH, ABS
2714 cells/mm3 1000 - 3500
MONO, ABS 874 cells/mm3 40 - 900
EOS, ABS 1850 H cells/mm3 30 - 600
BASO, ABS 83 cells/mm3 0 - 125
53 For Financial Professional Use Only
WBC Differential: Basophils
Possible Causes of Basophilia:
Decreased Levels:
Rare: leukemias, myeloid metaplasia, Hodgkin’s disease
- - -
54 For Financial Professional Use Only
Platelet Count
TEST RESULT UNITS REF RANGE WBC 5.2 x 1000/mm3 3.9 - 11.1 RBC 3.81 L x 106/mm3 4.20 - 5.70 HGB 14.5 g/dL 13.2 - 16.9 HCT 41.2 % 38.5 - 49.0 MCV 98 H fl 80 - 97 MCH 33.7 H pg 27.5 - 33.5 MCHC 35.3 % 32.0 - 36.0 RDW 11.8 % 11.0 - 15.0 PLT 172 x 1000/mm3 140 - 390 MPV 7.6 fl 7.5 - 11.5 NEUT % 40.1 % 38.0 - 80.0 LYMPH % 46.1 % 15.0 - 49.0 MONO % 12.9 % 0.0 - 13.0 EOS % 0.6 % 0.0 - 8.0 BASO % 0.3 % 0.0 - 2.0 NEUT, ABS 2085 cells/mm3 1650 - 8000 LYMPH, ABS 2397 cells/mm3 1000 - 3500 MONO, ABS 671 cells/mm3 40 - 900 EOS, ABS 31 cells/mm3 30 - 600 BASO, ABS 16 cells/mm3 0 - 125
55 For Financial Professional Use Only
Mean Platelet Volume (MPV)
• “Young” platelets, recently released from the bone marrow, are typically slightly larger
• Often elevated in immune or idiopathic thrombocytopenic purpura (ITP)
• In an individual with low platelet count (thrombocytopenia):
– Increased MPV indicates normal bone marrow response
– Decreased or low normal MPV may indicate impaired bone marrow response
56 For Financial Professional Use Only
Selected Causes of Abnormal Platelet Counts
Possible Causes of Thrombocytosis:
Possible Causes of Thrombocytopenia:
Common: “Reactive” thrombocytosis related to acute trauma, surgery, blood loss, iron deficiency, chronic infections (osteomyelitis), inflammatory diseases including rheumatoid arthritis and ulcerative colitis, splenectomy
Uncommon: polycythemia vera, essential thrombocytosis (plt count over 600,000), some cancers
Common: spurious lab result caused by platelet clumping, idiopathic or immune-mediated thrombocytopenia (ITP), medications, viral infection
Uncommon: hemolytic-uremic syndrome, leukemia, sepsis, hypersplenism
57 For Financial Professional Use Only
Case # 7
• 28 yo female applying for $100,000 term
• Paramedical exam: car accident 3 months ago
• Insurance labs: normal
• Medical records: MVA 3 months ago with airbag deployment, two broken ribs and fractured foot.
TEST RESULT UNITS REF RANGE WBC 10.9 x 1000/mm3 3.9 - 11.1 RBC 4.4 x 106/mm3 4.20 - 5.70 HGB 13.5 g/dL 13.2 - 16.9 HCT 41.3 % 38.5 - 49.0 MCV 96 fl 80 - 97
MCH 33.6 H pg 27.5 - 33.5 MCHC 34.9 % 32.0 - 36.0 RDW 11.8 % 11.0 - 15.0 PLT 481 H x 1000/mm3 140 - 390 MPV 11.3 fl 7.5 - 11.5
58 For Financial Professional Use Only
Idiopathic Thrombocytopenic Purpura (ITP)
• Although there are many causes of low platelet counts, including medications, infections, and hypersplenism, the term “ITP” is reserved for the autoimmune destruction of platelets; “Immune thrombocytopenic purpura”
• Immune system attacks and destroys platelets faster than they can be produced; red rash (purpura) and bleeding
• Some cases will remit with this alone and never recur
• If more severe, can usually be cured with splenectomy, but some will still have low platelets after splenectomy
• Prognosis depends on the current platelet count and the mode of treatment
• Mortality Concerns– Fatalities may occur due to severe bleeding or due to overwhelming
infection after splenectomy
59 For Financial Professional Use Only
Bone Marrow Disorders• All formed elements of the blood are made primarily in the bone marrow
• There is particular concern if all 3 cell lines are abnormal (RBCs, WBCs, and platelets), especially if:– the applicant is over age 50 and/or– there is an increased percentage of monocytes
• This suggests the possibility of diseases involving the bone marrow, and many of these diseases have very significant mortality concerns.
• Aplastic Anemia: diminished-absent precursor cells (pancytopenia)
• Myeloproliferative disorders: bone marrow cells grow too rapidly with over-production of blood cells and/or platelets– If this acceleration continues it may transform into cancer (usually leukemia)– Myeloproliferative disorders include:
• Essential thrombocytosis• Polycythemia vera• Myelofibrosis (possible pancytopenia)
• Myelodysplastic syndromes: ineffective blood cell production (pancytopenia)
60 For Financial Professional Use Only
Aplastic Anemia
• A disorder where the bone marrow stops producing blood cells (pancytopenia - all lines – RBC, WBC and platelets)
• Can be congenital (Fanconi anemia), or acquired
• Acquired form brought on by certain infections or drugs
• Prognosis depends on severity – most cases pose a very high mortality risk unless spontaneously remitted long ago
• Mortality Concerns:– The aplastic crisis may result in death due to infection,
bleeding, or severe anemia
– Complications of bone marrow transplant (graft vs. host disease)
61 For Financial Professional Use Only
Essential Thrombocytosis (ET)
• Also called essential thrombocythemia
• Megakaryocytes in the bone marrow produce too many platelets, which may be misshapen or may function poorly
• They may become so numerous as to cause clotting (risk of stroke)
• Platelet count at least 600k up to 1.5 million per mm3
• Prognosis depends on frequency of bleeding/clotting complications
• Also, increased risk for developing leukemia, especially chronic myelogenous leukemia (CML)
62 For Financial Professional Use Only
Polycythemia (rubra) vera
• Red cell progenitors start to lose control over their growth
• Can be treated with phlebotomy (removing blood) or marrow-suppressing medications
• Mortality Concerns
–Fatalities can occur due to clotting, or due to malignant transformation
63 For Financial Professional Use Only
Myelofibrosis
• A condition where the bone marrow becomes fibrotic (scarred)
• Can cause low counts of all cell lines (pancytopenia)
• Spleen and liver may become enlarged as they begin to serve as back-up producers of formed elements (extramedullary hematopoesis)
• Mortality Concerns: Decreasing counts of all formed elements may lead to death from infection, severe anemia, or bleeding
64 For Financial Professional Use Only
Myelodysplasia
• A bone marrow disorder of older individuals, where there is ineffective production of red blood cells, eventually may also involve the WBC and platelet lines (pancytopenia)
• Can be a precursor to leukemia
• Several subtypes, e.g., refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS)
• Treatment is supportive – transfusions and antibiotics
• Prognosis is generally poor
• Mortality Concerns: malignant transformation, severe anemia, infection, or bleeding
65 For Financial Professional Use Only
Case # 8
76 yo male applying for $2 million UL
• MD exam: type 2 diabetes, on Avandia
• Insurance labs: glucose 118, hemoglobin A1c 7.9%
• Medical records: mild anemia, normal iron studies, B12 and folate levels normal, no history of alcohol excess
TEST 7/08 RESULT 1/10 RESULT 8/10 RESULT UNITS REF RANGE
WBC 7.0 5.4 4.7 L K/µL 4.8 - 10.8
RBC 4.37 L 3.97 L 3.82 L x 106/mm3 4.40 - 5.70
HGB 13.7 L 11.8 L 11.5 L g/dL 14.0 - 18.0
HCT 42.1 35.4 L 34.4 L % 42.0 - 52.0
MCV 96.9 101.2 H 102.2 H fl 80 - 97
MCH 33.0 33.6 H 33.1 pg 27.5 - 33.5
MCHC 33.2 33.0 32.9 % 32.0 - 36.0
RDW 13.8 14.9 14.3 % 11.0 - 15.0
PLT 241 199 129 L K/µL 140 - 390
MPV 8.9 9.0 8.3 L fl 8.6 - 11.7
NEUT % 55.0 61.0 55.6 % 30.0 - 75.0
LYMPH % 34.8 27.7 31.7 % 10.0 - 50.0
MONO % 7.2 9.2 11.2 H % 2.0 - 10.0
EOS % 2.5 1.6 1.1 % 0.0 - 6.0
BASO % 0.5 0.5 0.4 % 0.0 - 2.0
66 For Financial Professional Use Only
Case # 8: CBCs dated 7/08, 1/10, 8/10
TEST 7/08 RESULT 1/10 RESULT 8/10 RESULT UNITS REF RANGE WBC 7.0 5.4 4.7 L K/µL 4.8 - 10.8 RBC 4.37 L 3.97 L 3.82 L x 106/mm3 4.40 - 5.70 HGB 13.7 L 11.8 L 11.5 L g/dL 14.0 - 18.0 HCT 42.1 35.4 L 34.4 L % 42.0 - 52.0 MCV 96.9 101.2 H 102.2 H fl 80 - 97 MCH 33.0 33.6 H 33.1 pg 27.5 - 33.5 MCHC 33.2 33.0 32.9 % 32.0 - 36.0 RDW 13.8 14.9 14.3 % 11.0 - 15.0 PLT 241 199 129 L K/µL 140 - 390 MPV 8.9 9.0 8.3 L fl 8.6 - 11.7 NEUT % 55.0 61.0 55.6 % 30.0 - 75.0 LYMPH % 34.8 27.7 31.7 % 10.0 - 50.0 MONO % 7.2 9.2 11.2 H % 2.0 - 10.0 EOS % 2.5 1.6 1.1 % 0.0 - 6.0 BASO % 0.5 0.5 0.4 % 0.0 - 2.0
68 For Financial Professional Use Only
Life insurance products are issued by MetLife Investors USA Insurance Company, Metropolitan Life Insurance Company and in New York only, by First MetLife Investors Insurance Company. All guarantees are based on the claims-paying ability and financial strength of the issuing insurance company. Variable products are distributed by MetLife Investors Distribution Company (MetLife Investors), Irvine, CA. September 2012
L0911208105[exp0912][All States][DC,GU,MP,PR,VI]